Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States

por Adeyemi, Ayoade, Razakariasa, Francesca, Chiorean, Alexandra, de Passos Sousa, Rui
Publicado 2022

Caplacizumab Model‐Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura

por Bergstrand, Martin, Hansson, Emma, Delaey, Bernard, Callewaert, Filip, De Passos Sousa, Rui, Sargentini‐Maier, Maria Laura
Publicado 2021

Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study

por Scully, Marie, de la Rubia, Javier, Pavenski, Katerina, Metjian, Ara, Knöbl, Paul, Peyvandi, Flora, Cataland, Spero, Coppo, Paul, Kremer Hovinga, Johanna A., Minkue Mi Edou, Jessica, De Passos Sousa, Rui, Callewaert, Filip, Gunawardena, Sriya, Lin, Julie
Publicado 2022